SCHEMBL31264087

SCHEMBL31264087

Cc1cc2c(c(C)n1)COC2=O

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 9/20 0.41
KCNJ1 P48048 2/20 0.40
ALDH1A1 P00352 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PDE1A P54750 1/20 0.37
PDE1B Q01064 1/20 0.37
PDE3B Q13370 1/20 0.37
PDE1C Q14123 1/20 0.37
PDE3A Q14432 1/20 0.37
CYP3A4 P08684 1/20 0.36
LMNA P02545 1/20 0.36
KCNH2 Q12809 1/20 0.35
GAA P10253 1/20 0.35
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9689749 0.82 ALOX5 (0.39) ALOX5KCNJ1ALDH1A1L3MBTL1KDM4E
SCHEMBL10177027 0.73 KCNJ1 (0.42) ALOX5KCNJ1ALDH1A1CYP3A4LMNA
SCHEMBL19566073 0.70 KCNJ1 (0.47) ALOX5KCNJ1ALDH1A1LMNAKCNH2
SCHEMBL20811853 0.67 KCNJ1 (0.40) ALOX5KCNJ1ALDH1A1KDM4EPDE3B
SCHEMBL31310219 0.67 CLK4 (0.37) ALOX5
SCHEMBL23513237 0.66 KCNJ1 (0.42) ALOX5KCNJ1ALDH1A1CYP3A4LMNA
SCHEMBL286354 0.66 KCNJ1 (0.46) ALOX5KCNJ1ALDH1A1PDE1APDE1B
SCHEMBL31633611 0.65 ALOX15 (0.34) ALOX5ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL15444576 0.65 NUAK1 (0.35) KCNJ1
SCHEMBL12444323 0.64 KDM4E (0.45) KCNJ1KDM4EKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120476110-B Nitrogen-containing heterocyclic derivative inhibitor, preparation method and application thereof SHANGHAI HANSOH BIOMEDICAL Co.,Ltd. (CN) 2026-05-26 CN disclosed
EP-4741376-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Hansoh Biomedical Co., Ltd. (CN) 2026-05-13 EP disclosed
US-12612403-B2 Nitrogen-containing heterocyclic derivative inhibitor, and preparation method therefor and use thereof SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) 2026-04-28 US disclosed
US-20250388578-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2025-12-25 US disclosed
WO-2025007915-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海翰森生物医药科技有限公司 2025-01-09 WO disclosed
CN-119264042-A Cyclopentane derivative-containing inhibitor, preparation method and application thereof 上海翰森生物医药科技有限公司 2025-01-07 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12612403-B2 Nitrogen-containing heterocyclic derivative inhibitor, and preparation method therefor and use thereof FAR1, NPR1, CBR1 ALOX5 978/4885KCNJ1 981/4885ALDH1A1 625/4885
US-20250388578-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF FAR1, NPR1, CBR1 ALOX5 978/4885KCNJ1 981/4885ALDH1A1 625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.